JPMorgan Chase & Co. Issues Pessimistic Forecast for HealthEquity (NASDAQ:HQY) Stock Price

HealthEquity (NASDAQ:HQY) had its price objective reduced by JPMorgan Chase & Co. from $129.00 to $123.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 55.03% from the stock’s previous close.

A number of other equities analysts also recently weighed in on HQY. Royal Bank Of Canada dropped their target price on shares of HealthEquity from $110.00 to $100.00 and set an “outperform” rating for the company in a research note on Wednesday. BTIG Research dropped their price objective on HealthEquity from $130.00 to $110.00 and set a “buy” rating for the company in a report on Tuesday, February 17th. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a report on Thursday, January 22nd. Jefferies Financial Group set a $108.00 price target on HealthEquity in a research report on Thursday, February 19th. Finally, Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Monday, January 19th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $109.79.

HealthEquity Price Performance

HealthEquity stock traded down $0.06 during mid-day trading on Wednesday, hitting $79.34. 654,862 shares of the company were exchanged, compared to its average volume of 1,024,710. HealthEquity has a 1-year low of $72.76 and a 1-year high of $116.65. The company has a market capitalization of $6.78 billion, a PE ratio of 36.37, a price-to-earnings-growth ratio of 0.98 and a beta of 0.26. The business has a fifty day moving average of $81.30 and a 200 day moving average of $90.27. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.05. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm had revenue of $334.59 million for the quarter, compared to analyst estimates of $332.48 million. The firm’s revenue for the quarter was up 7.3% on a year-over-year basis. As a group, sell-side analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

Insiders Place Their Bets

In other news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the sale, the executive vice president directly owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president owned 45,742 shares of the company’s stock, valued at $4,366,073.90. This trade represents a 19.33% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.50% of the company’s stock.

Institutional Trading of HealthEquity

Several institutional investors and hedge funds have recently bought and sold shares of HQY. Sivia Capital Partners LLC acquired a new stake in shares of HealthEquity in the second quarter valued at approximately $306,000. Allworth Financial LP increased its holdings in shares of HealthEquity by 283.1% during the 2nd quarter. Allworth Financial LP now owns 747 shares of the company’s stock worth $78,000 after acquiring an additional 552 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in HealthEquity by 2.5% in the 2nd quarter. PNC Financial Services Group Inc. now owns 13,390 shares of the company’s stock valued at $1,403,000 after acquiring an additional 327 shares during the period. Police & Firemen s Retirement System of New Jersey raised its stake in HealthEquity by 3.7% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 19,264 shares of the company’s stock valued at $2,018,000 after acquiring an additional 692 shares during the period. Finally, Banco Bilbao Vizcaya Argentaria S.A. acquired a new stake in HealthEquity during the 2nd quarter valued at $492,000. Institutional investors own 99.55% of the company’s stock.

Key Stories Impacting HealthEquity

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Q4 results beat estimates and management raised fiscal‑2027 guidance — Company reported record revenue, higher net income and new HSAs from sales, and lifted its outlook, which supports upside to earnings and cash flow expectations. HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026
• Positive Sentiment: Quarterly earnings and revenue topped analyst estimates (EPS $0.95 vs. consensus ~$0.90; revenue ~$334.6M vs. ~$332.5M), reinforcing the beat-and-raise narrative and validating margin improvement. HealthEquity (HQY) Beats Q4 Earnings and Revenue Estimates
• Positive Sentiment: Analyst upgrade: Seeking Alpha upgraded HQY citing improved cash economics and better free‑cash‑flow conversion, which can support valuation multiple expansion. HealthEquity: Attractive Given Improved Cash Economics (Rating Upgrade)
• Neutral Sentiment: Earnings call and transcript coverage provide detail on HSA growth, margin drivers and FY27 assumptions — useful for modeling but largely confirm the press release takeaways. HealthEquity (HQY) Q4 2026 Earnings Transcript
• Neutral Sentiment: Additional transcripts and analyst pre‑earnings coverage summarize key metrics and consensus expectations; informative for traders but not new directional catalysts. HealthEquity, Inc. (HQY) Q4 2026 Earnings Call Transcript
• Negative Sentiment: Royal Bank of Canada cut its price target from $110 to $100 while keeping an Outperform rating — a reduction in analyst price target can temper some upside expectations and weigh on near‑term sentiment. Benzinga: RBC Lowers Price Target on HealthEquity

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.